A new study has revealed that even if current global carbon emissions pledges are fulfilled, around 1.4 million more people in the UK could face heightened risk of coastal flooding by the year 2200.

A laboratory study by the University of Cambridge found that commonly used sweeteners can alter the growth of gut bacteria. The effects varied when sweeteners were combined with medicines and other substances, although further research is needed to determine their relevance to human health.

A study has revealed that mindfulness and tai chi practices eased sleep problems, fatigue, and pain of patients post their cancer treatment.

A review of research on repeated weight loss and regain suggests that yo‑yo dieting is not necessarily as harmful as it is often portrayed.

Despite substantial investment in pharmaceutical R&D, clinical success rates remain low. As it stands, 90 % of drug candidates entering human trials fail due to unforeseen toxicity or limited efficacy in humans. A key contributor to this attrition is the limited predictive power of traditional preclinical models, particularly 2D cell cultures and animal studies, which often fall short in recapitulating the complexity of human biology. This gap is particularly evident in oncology and organ-specific toxicity assessments, where cellular context and microenvironmental interactions play a critical role in drug response.

Researchers have recently revealed that the presence of certain bacteria in the gut microbiota as well as fluctuations in a person’s metabolism can be seen in people who go on to develop type 2 diabetes years later.

New research highlights that food anaphylaxis, a severe and rapid allergic reaction to food, can prove fatal in children if life-saving adrenaline autoinjector (Epipen) is not administered on time.

Researchers have found that parents think that their children are getting sufficient sleep but that not the case as a study in Rhode Island in the USA reveals that kids sleep less than their parents realize.

Researchers have developed a method to analyze blood samples with just 5 % cancer DNA, compared to the 15–20 % required today—opening the door to improved cancer care and tumor monitoring.

Researchers have discovered a molecular mechanism that regulates whether the cells of an aggressive colorectal cancer are conventional or inverted when they spread in the body. The discovery can help identify patients who have an elevated risk that the cancer metastasises to the abdominal cavity.